ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Susumu Manabe
Hiroyuki Tanaka
Tomoya Yoshizaki
Noriyuki Tabuchi
Hirokuni Arai
Makoto Sunamori
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manabe, S.
Right arrow Articles by Sunamori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manabe, S.
Right arrow Articles by Sunamori, M.
Related Collections
Right arrow Cardiac - pharmacology

Ann Thorac Surg 2005;79:831-835
© 2005 The Society of Thoracic Surgeons

Original article: Cardiovascular

Effects of the Postoperative Administration of Diltiazem on Renal Function After Coronary Artery Bypass Grafting

Susumu Manabe, MD, Hiroyuki Tanaka, MD, PhD*, Tomoya Yoshizaki, MD, Noriyuki Tabuchi, MD, PhD, Hirokuni Arai, MD, PhD,, Makoto Sunamori, MD, PhD

Department of Cardiothoracic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Accepted for publication June 25, 2004.

* Address reprint requests to Dr Tanaka, Tokyo Medical and Dental University, Graduate School of Medicine, Department of Cardiothoracic Surgery, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan (E-mail: hiroyuki-tanaka.tsrg{at}tmd.ac.jp).

BACKGROUND: Radial artery grafts are used for coronary artery bypass grafting (CABG), and postoperative antispasm therapy with diltiazem is performed widely. Some investigators have warned that diltiazem administration after cardiac surgery is harmful to renal function. We designed a retrospective study to investigate the renal and hemodynamic effects of the postoperative administration of diltiazem in patients undergoing CABG.

METHODS: Subjects were 90 consecutive CABG patients. All were treated with diltiazem during surgery (a 0.1 mg/kg bolus injection followed by continuous infusion at 2 µg · kg–1 · min–1). In the 50 patients (diltiazem group) with a radial artery graft, intravenous diltiazem administration was continued until the oral intake of diltiazem (90 mg/d) was begun to avoid graft spasms. In the remaining 40 patients without a radial artery graft, diltiazem was not continued postoperatively (control group). Postoperative renal function, assessed by serum creatinine level and creatinine clearance, and hemodynamic variables (heart rate, arterial pressure, pulmonary wedge pressure, cardiac index, left ventricular stroke work index) was compared between the two groups.

RESULTS: Renal function: Serum creatinine concentrations on postoperative days 1 through 7 were lower, and the endogenous creatinine clearance in the early postoperative period was higher in diltiazem group than in control group, although the differences were not significant. Hemodynamics: Heart rate was lower in diltiazem group than in the control group, but blood pressure, pulmonary wedge pressure, cardiac index, left ventricular stroke work index, and urinary output were similar between the groups.

CONCLUSIONS: Our results confirmed that intravenous diltiazem treatment in patients undergoing CABG is not harmful to renal function.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.